Contracts › 140D0426C0021
140D0426C0021: Physical Sciences Inc. (PSI) Aims to Develop and Commercialize a First-Of-Its-Kind In-Line Cytometry Process Analytical Technology (ILC-PAT) That Enables Real-Time, Single-Cell Level Monitoring of Critical Bioprocess Parameters to Improve the Manufac
Awarded to Physical Sciences Inc. by Departmental Offices.
$3.5Mobligated
$3.5Mpotential value
28 February 2029current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 140D0426C0021 |
|---|---|
| Awardee | Physical Sciences Inc. |
| Awarding agency | Departmental Offices |
| Awarding office | IBC ACQ SVCS DIRECTORATE (00004) |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN13 Health R&D Services; Health Care Services; Experimental Development |
| Place of performance | MA |
| Offers received | 2 |
| Period of performance | 26 February 2026 to 28 February 2029 |
| Potential end | 31 March 2029 |
| Estimated recompete solicitation | ~Q3 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record